Potential Protective Effect of Zingiber officinale in Comparison to Rosuvastatin on High-fat diet-induced Non-alcoholic Fatty Liver Disease in Rats


  • Osama Ibrahim Ramadan Department of Histology, Damietta Faculty of Medicine, Al-Azhar University, Cairo, Egypt https://orcid.org/0000-0002-7916-5494
  • Mohamed Nasr Department of Histology, Faculty of Medicine, Al Azhar University, Cairo, Egypt
  • Osama M.M. Abd El-Hay Department of Physiology, Faculty of Medicine, Al Azhar University, Cairo, Egypt
  • Abdulkarim Hasan Department of Pathology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
  • Ezz-Eldin E. Abd-Allah Department of Histology, Damietta Faculty of Medicine, Al-Azhar University, Cairo, Egypt
  • Mohammed E. Mahmoud Department of Histology, Damietta Faculty of Medicine, Al-Azhar University, Cairo, Egypt
  • Fatma M. Abd-Allah Department of Histology, Damietta Faculty of Medicine, Al-Azhar University, Cairo, Egypt
  • Tamer M. M. Abuamara Department of Histology, Faculty of Medicine, Al Azhar University, Cairo, Egypt
  • Mohammed G. A. Hablas Department of Histology, Assiut Faculty of Medicine, Al Azhar University, Cairo, Egypt
  • Moaaz M. Y. Awad Department of Anatomy and Embryology, Damietta Faculty of Medicine, Al-Azhar University, Cairo, Egypt
  • Mahmoud Diab Department of Anatomy and Embryology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
  • Ahmed M. Taha Department of Pharmacology, Faculty of Medicine, Helwan University, Helwan, Egypt
  • Mohamed K. Radwan Department of Biochemistry, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
  • Nancy H. Abulkhair Department of Biochemistry, Faculty of Pharmacy for Girls, Al-Azhar University, Cairo, Egypt
  • Alsayed A. Abdel-Hady Department of Anatomy and Embryology, Faculty of Medicine, Helwan University, Helwan, Egypt




Zingiber officinale, Rosuvastatin, Ginger, Non-alcoholic Fatty Liver Disease


BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a common liver disease affecting nearly 25% of adults worldwide with related risk factors including obesity, metabolic, and inflammatory diseases. Many therapeutic remedies of natural or synthetic properties were used.

AIM: This study aimed to investigate and compare the effects of ginger/rosuvastatin (ROSU) on the liver of rats with induced NAFLD.

MATERIALS AND METHODS: Forty adult male albino rats were used in this study and divided into four equal subgroups, Group I, control received the standard rat chow diet and given normal saline (1 ml/kg/day), Group II, high-fat diet (HFD) group, Group III, received HFD+ ROSU (15 mg/kg/day), and Group IV, HFD+ Zingiber officinale (10% W/V) for 6 weeks. At the end of our experiment, the rats were sacrificed then blood samples were collected for biochemical analysis of lipid profiles and liver enzymes, liver specimen was prepared for light and electron microscopic examination, and measurement of tissue level of malondialdehyde.

RESULTS: NAFLD caused degenerative changes and lipid deposition in liver cells as evidenced by microscopic results and laboratory tests. Treatment with ginger/ROSU alleviated those changes.

CONCLUSION: Ginger and ROSU could ameliorate liver functions in NAFLD and ginger effect is superior to ROSU.


Download data is not yet available.


Metrics Loading ...

Plum Analytics Artifact Widget Block


Solanki ND, Vadi K, Patel S. Alleviating effect of Ficus racemosa in high-fat-high-fructose diet-induced non-alcoholic fatty liver disease. Indian J Physiol Pharmacol. 2021;65(1):12-20. https://doi.org/10.25259/ijpp_406_2020 DOI: https://doi.org/10.25259/IJPP_406_2020

Bunbupha S, Pakdeechote P, Maneesai P, Prasarttong P. Nobiletin alleviates high-fat diet-induced nonalcoholic fatty liver disease by modulating AdipoR1 and gp91phox expression in rats. J Nutr Biochem. 2021;87:108526. https://doi.org/10.1016/j.jnutbio.2020.108526 PMid:33096235 DOI: https://doi.org/10.1016/j.jnutbio.2020.108526

Ogunlana OO, Ogunlana OE, Adekunbi TS, Adetuyi BO, Adegboye BE, Iheagwam FN. Anti-inflammatory mechanism of Ruzu bitters on diet-induced nonalcoholic fatty liver disease in male Wistar rats. Evid Based Complement Alternat Med. 2020;2020:5246725. https://doi.org/10.1155/2020/5246725 DOI: https://doi.org/10.1155/2020/5246725

Abdul-Kafy AL, Sharaf HH, Abdul-Aziz AI, Keshka MG. Effect of metformin, pioglitazone and rosuvastatin on induced non-alcoholic fatty liver in rats. Egypt J Hosp Med. 2019;76(4):4021-8. https://doi.org/10.21608/ejhm.2019.42129 DOI: https://doi.org/10.21608/ejhm.2019.42129

Nguyen V, George J. Nonalcoholic Fatty liver disease management: dietary and lifestyle modifications. Semin Liver Dis. 2015;35(3):318-37. https://doi.org/10.1055/s-0035-1562950 PMid:26378647 DOI: https://doi.org/10.1055/s-0035-1562950

Kandeil MA, Hashem RM, Mahmoud MO, Hetta MH, Tohamy MA. Zingiber officinale extract and omega-3 fatty acids ameliorate endoplasmic reticulum stress in a nonalcoholic fatty liver rat model. J Food Biochem. 2019;43(12):e13076. https://doi.org/10.1111/jfbc.13076 PMid:31608477. DOI: https://doi.org/10.1111/jfbc.13076

Faran SA, Asghar S, Khalid SH, Khan IU, Asif M, Khalid I, et al. Hepatoprotective and renoprotective properties of lovastatinloaded ginger and garlic oil nanoemulsomes: Insights into serum biological parameters. Medicina. 2019;55(9):579. https://doi.org/10.3390/medicina55090579 PMid:31505863 DOI: https://doi.org/10.3390/medicina55090579

Abdel-Daim MM, Abdeen A. Protective effects of rosuvastatin and Vitamin E against fipronil-mediated oxidative damage and apoptosis in rat liver and kidney. Food Chem Toxicol. 2018;114:69-77. https://doi.org/10.1016/j.fct.2018.01.055 PMid:29432839 DOI: https://doi.org/10.1016/j.fct.2018.01.055

Kalantari H, Rastmanesh M. Protective property of cichorium intybus in CCL4 induced liver damage in mice. Arch Iran Med. 2000;3(1):28-30.

Dizaye KF, Mohammed HH. Hypolipidemic efficacy of Zingiber officinale extract in comparison with fenofibrate, rosuvastatin and ezetimibe in hyperlipidemic rats. JSMC. 2019;9(3):211-7. https://doi.org/10.17656/jsmc.10208 DOI: https://doi.org/10.17656/jsmc.10208

Draper HH, Squires EJ, Mahmoodi H, Wu J, Agarwal S, Hadley M. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med. 1993;15(4):353-63. https://doi.org/10.1016/0891-5849(93)90035-s PMid:8225017 DOI: https://doi.org/10.1016/0891-5849(93)90035-S

Reynolds ES. The use of lead citrate at high pH as an electronopaque stain in electron microscopy. J Cell Biol. 1963;17(1):208-12. https://doi.org/10.1083/jcb.17.1.208 PMid:13986422 DOI: https://doi.org/10.1083/jcb.17.1.208

Eissa AA, Abdelateef AS, Elkotby HM. Potential effect of curcumin versus atorvastatin on hepatic and metabolic changes in rat model of metabolic syndrome. Int J Med Arts. 2021;3(3):1507-15. https://doi.org/10.21608/ijma.2021.61857.1267 DOI: https://doi.org/10.21608/ijma.2021.61857.1267

Mohammed NA, Fadlelmula TM, Alameen AA. The effect of ethanolic pulp extract of Adansonia digitata in hyperlipidemic experimental albino rats. World J Pharm Res. 2017;6(7):365-71. https://doi.org/10.20959/wjpr20177-8786 DOI: https://doi.org/10.20959/wjpr20177-8786

Li QP, Dou YX, Huang ZW, Chen HB, Li YC, Chen JN, et al. Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats. Phytomedicine. 2021;85:153550. https://doi.org/10.1016/j.phymed.2021.153550 PMid:33831691 DOI: https://doi.org/10.1016/j.phymed.2021.153550

Mamikutty N, Thent ZC, Suhaimi FH. Fructose-drinking water induced nonalcoholic fatty liver disease and ultrastructural alteration of hepatocyte mitochondria in male Wistar Rat. Biomed Res Int. 2015;2015:895961. https://doi.org/10.1155/2015/895961 PMid:26273656 DOI: https://doi.org/10.1155/2015/895961

Han H, Li X, Guo Y, Zheng M, Xue T, Wang L. Plant sterol ester of α-linolenic acid ameliorates high-fat diet-induced nonalcoholic fatty liver disease in mice: Association with regulating mitochondrial dysfunction and oxidative stress via activating AMPK signaling. Food Funct. 2021;12(5):2171-88. https://doi.org/10.1039/d0fo02623a PMid:33566044 DOI: https://doi.org/10.1039/D0FO02623A

Qiu Y, Sui X, Zhan Y, Xu C, Li X, Ning Y, et al. Steroidogenic acute regulatory protein (StAR) overexpression attenuates HFD-induced hepatic steatosis and insulin resistance. Biochim Biophys Acta Mol Basis Dis. 2017;1863(4):978-90. https://doi.org/10.1016/j.bbadis.2017.01.026 DOI: https://doi.org/10.1016/j.bbadis.2017.01.026

Mahmouda AM, Noha AR, El-Bitar HI, Afifi AH. Potential protective effect of curcumin in high-fat diet-induced nonalcoholic fatty liver disease in rats. J Curr Med Res Pract. 2021;6(1):92. https://doi.org/10.4103/jcmrp.jcmrp_37_20 DOI: https://doi.org/10.4103/JCMRP.JCMRP_37_20

El Seedy GM, El-Shafey ES, Elsherbiny ES. Ziziphus spinachristi (L.) fortified with Camellia sinensis mediates apoptosis, Notch-1 signaling, and mitigates obesity-induced non-alcoholic fatty liver. J Food Biochem. 2021;45(8):e13849. https://doi.org/10.1111/jfbc.13849 PMid:34245170 DOI: https://doi.org/10.1111/jfbc.13849

Golmohammadi R, Dashti GR, Vahedi P. Studying the effect of Vitamin C on blood serum lipoproteins and liver tissue in high cholesterol-fed rabbits. KAUMS J (FEYZ). 2009;13(1):20-4.

Omar ZM, Ahmed AA, El-Bakry MH, Ahmed MA, Hasan A. Metformin versus silymarin as hepatoprotective agents in mice fibrotic model caused by carbon tetrachloride. In: Annales Pharmaceutiques Françaises. Amsterdam, Netherlands: Elsevier, Masson; 2022. https://doi.org/10.1016/j.pharma.2022.01.005 DOI: https://doi.org/10.1016/j.pharma.2022.01.005

Jahromi HK. Examining the effect of selenium in improving non-alcoholic fatty liver disease in rats. Asian J Pharm. 2018;12(1):2059.

Shalaby MA, Saifan HY. Some pharmacological effects of cinnamon and ginger herbs in obese diabetic rats. J Intercult Ethnopharmacol. 2014;3(4):144-9. https://doi.org/10.5455/jice.20140818050741 PMid:26401364 DOI: https://doi.org/10.5455/jice.20140818050741

Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic. Hepatology. 2003;37(4):917-23. https://doi.org/10.1053/jhep.2003.50161 PMid:12668987 DOI: https://doi.org/10.1053/jhep.2003.50161

Zaitone S, Hassan N, El-Orabi N, El-Awady S. Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease. Eur J Pharmacol. 2011;662(1-3):70-7. https://doi.org/10.1016/j.ejphar.2011.04.049 PMid:21549113 DOI: https://doi.org/10.1016/j.ejphar.2011.04.049

Neuschwander-Tetri BA. Non-alcoholic fatty liver disease. BMC Med. 2017;15(1):45. https://doi.org/10.1186/s12916-017-0806-8 PMid:28241825 DOI: https://doi.org/10.1186/s12916-017-0806-8

Dwivedi DK, Jena GB. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(4):705-16. https://doi.org/10.1007/s00210-019-01773-5 PMid:31834465 DOI: https://doi.org/10.1007/s00210-019-01773-5

Elsyade R, El Sawaf E, Gaber D. Hazards of chronic exposure to nonylphenol: Concomitant effect on non-alcoholic fatty liver disease in male albino rats. Open Access Maced J Med Sci. 2021;9(A):548-55. https://doi.org/10.3889/oamjms.2021.6237 DOI: https://doi.org/10.3889/oamjms.2021.6237

Antonopoulos S, Mikros S, Mylonopoulou M, Kokkoris S, Giannoulis G. Rosuvastatin as a novel treatment of nonalcoholic fatty liver disease in hyperlipidemic patients. Atherosclerosis. 2006;184(1):233-4. https://doi.org/10.1016/j.atherosclerosis.2005.08.021 PMid:16168995 DOI: https://doi.org/10.1016/j.atherosclerosis.2005.08.021

Berroukche A, Attaoui A, Loth M. Comparative study between effects of ethanol extract of Zingiber officinale and Atorvastatine on lipid profile in rats. J Pharmacogn Phytother. 2016;8(8):155-62. https://doi.org/10.5897/jpp2015.0369 DOI: https://doi.org/10.5897/JPP2015.0369

Prasad SS, Kumar S, Vajpeyee SK, Bhavsar VH. To establish the effect of ginger-juice Zingiber officinale (Zingiberaceae) on important parameters of lipid profile. Int J Pharm Sci Res. 2012;3(4):352-6.

ElRokh SM, Yassin NA, El-Shenawy SM, Ibrahim BM. Antihypercholesterolaemic effect of ginger rhizome (Zingiber officinale) in rats. Inflammopharmacology. 2010;18(6):309-15. https://doi.org/10.1007/s10787-010-0053-5 PMid:20730603 DOI: https://doi.org/10.1007/s10787-010-0053-5

El-Hameed A, Noura E, Heshmat HA. Effect of ginger aqueous extract on some reproductive and antioxidant parameters in male rabbits. Alexandria J Vet Sci. 2019;60(2):38-45. https://doi.org/10.5455/ajvs.24544 DOI: https://doi.org/10.5455/ajvs.24544

Khaki A, Fathiazad F, Nouri M, Khaki AA, Ozanci CC, Ghafari-Novin M, et al. The effects of ginger on spermatogenesis and sperm parameters of rat. Int J Reprod Biomed. 2009;7(1):7. https://doi.org/10.1016/s1472-6483(12)60133-3 DOI: https://doi.org/10.1016/S1472-6483(12)60133-3

Abidah SN, Anggraini FD, Nisa F, Hasina SN. The effect of ginger herbal drink on hyperemesis gravidarum in the first trimester pregnant women. Open Access Maced J Med Sci. 2022;10(G):64-8. https://doi.org/10.3889/oamjms.2022.7955 DOI: https://doi.org/10.3889/oamjms.2022.7955

Abd-Allah OM, El-Din AA. The possible protective effect of ginger against intestinal damage induced by methotrexate in rats. Med J Cairo Univ. 2013;81(1):1073-84.




How to Cite

Ramadan OI, Nasr M, El-Hay OMA, Hasan A, Abd-Allah E-EE, Mahmoud ME, Abd-Allah FM, Abuamara TMM, Hablas MGA, Awad MMY, Diab M, Taha AM, Radwan MK, Abulkhair NH, Abdel-Hady AA. Potential Protective Effect of Zingiber officinale in Comparison to Rosuvastatin on High-fat diet-induced Non-alcoholic Fatty Liver Disease in Rats. Open Access Maced J Med Sci [Internet]. 2022 Apr. 30 [cited 2023 Mar. 28];10(A):916-23. Available from: https://oamjms.eu/index.php/mjms/article/view/9643

Most read articles by the same author(s)